This information was published on 2025-01-07T15:10:19 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2508654 |
| (220) |
19 Dec 2024
|
| (300) |
JM, 25 Jun 2024, 92637
JM, 01 Jul 2024, 92673 |
| (511) (510) |
Class 5
Pharmaceutical preparations for suppressing, reducing, eliminating smoking and the urge to smoke; pharmaceutical preparations for treating drug and alcohol abuse and addiction; pharmaceutical preparations for treating nicotine addiction; pharmaceutical preparations for nicotine replacement therapy; pharmaceutical preparations in tablet, in lozenge form for suppressing, reducing, eliminating smoking and the urge to smoke; dietetic substances adapted for medical use; medicated preparations and substances for suppressing, reducing, eliminating smoking and the urge to smoke; patches for medical purposes, namely nicotine patches for use as aids to stop smoking; chewing gum for suppressing, reducing, eliminating smoking and the urge to smoke; nicotine mouth sprays for medical purposes; loose and pre-packaged powder tobacco (snus) for medical purposes; pouches, chewing gum, lozenges, tablets and patches containing nicotine to aid in smoking cessation |
| (540) |
|
| (730) |
British American Tobacco (Brands) Limited
|
| (750) |
Baker McKenzie
|
Find out more about publications on the About page.